Clinical Reasoning: Heart to swallow
Citation Manager Formats
Make Comment
See Comments

Article Information
- First Published May 16, 2016.
Author Disclosures
- David J. van Westerloo, MD, PhD,
- Daniela Q. Barge-Schaapveld, MD, PhD,
- Hennie Bikker, PhD,
- Martijn S. van Noorden, MD, PhD and
- Martijn R. Tannemaat, MD, PhD
- David J. van Westerloo, MD, PhD,
NONE
NONE
NONE
Netherlands Journal of Critical Care Medicine, associate editor, 2015.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Daniela Q. Barge-Schaapveld, MD, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Hennie Bikker, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Martijn S. van Noorden, MD, PhD and
Scientific advisory board Dutch GHB Monitor. Non-commercial; no financial compensation.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Martijn R. Tannemaat, MD, PhD
Araim Pharmaceuticals
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Araim Pharmaceuticals, 2014
NONE
NONE
- From the Departments of Intensive Care (D.J.v.W.), Cardiogenetics (D.Q.B.-S.), Psychiatry (M.S.v.N.), and Neurology (M.R.T.), Leiden University Medical Centre, Leiden; and Department of Clinical Genetics (H.B.), Academic Medical Centre, Amsterdam, the Netherlands.
- Correspondence to Dr. van Westerloo: djvanwesterloo{at}lumc.nl
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease
Dr. Rizwan S. Akhtar and Dr. Sarah Brooker
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Articles
Lithium carbonate in amyotrophic lateral sclerosisLack of efficacy in a dose-finding trialA. Chiò, G. Borghero, A. Calvo et al.Neurology, August 11, 2010 -
Clinical/Scientific Notes
Reversible right vagal neuropathySrikanth Muppidi, Puneet K. Gupta, Steven Vernino et al.Neurology, October 05, 2011 -
Article
Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trialsRuben P.A. van Eijk, Ashley R. Jones, William Sproviero et al.Neurology, October 04, 2017 -
Articles
Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosisExamining a more efficient trial designR.G. Miller, D.H. Moore, D.A. Forshew et al.Neurology, August 03, 2011